Newly-developed medication can be an effective means of curbing alcohol dependence when paired with psychological counseling, according to a new study published in JAMA.
In the first large, randomized study in the United States that tested the efficacy of FDA-approved drugs for alcohol dependents either combined with or without therapy, a large team of researchers from across the U.S. found that acamprosate (Campral) and naltrexone (Revia) successfully help users stop drinking when combined with psychological treatment. Right now, most doctors either prescribe drugs or treatment, but rarely both.
Two other drugs, nalmefene (Selincro) and topiramate (Topamax), can also help patients stop drinking, the study found.
Eight million people in the United States are currently alcohol dependent. Alcoholism can case liver and brain damage, as well as damage to other organs, and can increase the likelihood of dying early by three times.
More Must-Reads from TIME
- Donald Trump Is TIME's 2024 Person of the Year
- Why We Chose Trump as Person of the Year
- Is Intermittent Fasting Good or Bad for You?
- The 100 Must-Read Books of 2024
- The 20 Best Christmas TV Episodes
- Column: If Optimism Feels Ridiculous Now, Try Hope
- The Future of Climate Action Is Trade Policy
- Merle Bombardieri Is Helping People Make the Baby Decision
Write to Eliana Dockterman at eliana.dockterman@time.com